PHARMING GRP SP. ADRS (PHG) — Net Asset Quality Index
PHARMING GRP SP. ADRS (PHG) has a Net Asset Quality Index of 55.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €499.96 Million minus total liabilities of €222.86 Million yields net assets of €277.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read PHG current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
PHARMING GRP SP. ADRS Net Asset Quality Index Over Time (2021–2025)
This chart shows how PHARMING GRP SP. ADRS's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 55.4%, representing net assets of €277.10 Million against total assets of €499.96 Million EUR. For live market cap and overall valuation, see PHARMING GRP SP. ADRS (PHG) total market value.
Annual Net Asset Quality Index for PHARMING GRP SP. ADRS (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check PHARMING GRP SP. ADRS (PHG) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.4% | €277.10 Million | €499.96 Million | €222.86 Million | ▲ +0.2 pp |
| 2024 | 55.3% | €221.06 Million | €399.99 Million | €178.92 Million | ▲ +8.0 pp |
| 2023 | 47.3% | €218.78 Million | €462.85 Million | €244.07 Million | ▼ -0.8 pp |
| 2022 | 48.1% | €204.64 Million | €425.80 Million | €221.16 Million | ▼ -0.5 pp |
| 2021 | 48.6% | €192.92 Million | €397.31 Million | €204.40 Million | — |